Account

Posts of Robert F. Kennedy Jr

newest first

#1413Video
Views957−56%vs avg
Forwards5
Reactions23
Comments—
#1412Video
Views2,319+6%vs avg
Forwards78
Reactions104
Comments—
#1411Video
Views2,473+13%vs avg
Forwards36
Reactions101
Comments—
Views growthHide views growth

Views growth

Hours after publication

Show as table
Hours after publicationViews
0 h0
3 h687
17 h2,473
  1. After 24 hours2,473
  2. Total to date2,473
#1410Video
Views1,673−23%vs avg
Forwards8
Reactions29
Comments—
Views growthHide views growth

Views growth

Hours after publication

Show as table
Hours after publicationViews
0 h0
3 h608
17 h1,295
31 h1,673
  1. After 24 hours1,673
  2. Total to date1,673
#1409Video
Views1,683−23%vs avg
Forwards13
Reactions123
Comments—
Views growthHide views growth

Views growth

Hours after publication

Show as table
Hours after publicationViews
0 h0
8 h1,038
37 h1,683
  1. After 6 hours1,038
  2. Total to date1,683
#1407Video

HHS is putting $20 MILLION toward exploring new mental health treatments, including ketamine, psilocybin, and ibogaine. And unlike traditional drug trials, the research findings will be open to the public, not locked away by pharmaceutical companies. “The National Institute of Mental Health has opened a $20 million funding opportunity to establish a research network focused on rapid-acting psychotropic drugs.” “The network will study treatments including ketamine, esketamine, psilocybin, and other emerging approaches for serious mental illness.” “We also want experts and the public to help inform the design of our ibogaine trials.” “FDA has opened a request for information seeking comments, data, and recommendations on early phase studies.” “The comments are due on November 20th. I encourage researchers, clinicians, veterans, and families, and other members of the public to contribute their comments.” “We will also require transparency from the teams receiving these awards.” “Awardees will share research data with the drug development community while protecting patient privacy.” “Most of the time that these trials take place, the information is proprietary and the drug companies do not share it.” “We are requiring the companies to open source all of their data so that the public will have the best information.” “So competitors and other people who want to develop these interventions will have the immediate advantage of seeing what works and what doesn't work.” “Negative findings can prevent researchers from repeating unsuccessful approaches.” “We need those results as much as we need evidence of benefits.” - @RobertKennedyJr

Open in Telegram
Views2,011−8%vs avg
Forwards17
Reactions94
Comments—
Views growthHide views growth

Views growth

Hours after publication

Show as table
Hours after publicationViews
0 h0
39 h1,774
67 h2,011
  1. Total to date2,011
#1406Video
Views2,201+1%vs avg
Forwards44
Reactions192
Comments—
Views growthHide views growth

Views growth

Hours after publication

Show as table
Hours after publicationViews
0 h0
62 h2,115
77 h2,201
  1. Total to date2,201
#1405Video
Views2,608+19%vs avg
Forwards6
Reactions22
Comments—
#1404Video
Views1,903−13%vs avg
Forwards16
Reactions120
Comments—
#1403Video
Views1,955−11%vs avg
Forwards13
Reactions145
Comments—
#1402Video
Views1,923−12%vs avg
Forwards7
Reactions38
Comments—
#1401Video
Views2,090−4%vs avg
Forwards22
Reactions119
Comments—
#1400Video
Views1,886−14%vs avg
Forwards12
Reactions114
Comments—
#1399Video
Views2,017−8%vs avg
Forwards8
Reactions67
Comments—
#1398Video
Views2,143−2%vs avg
Forwards5
Reactions136
Comments—
#1396Video
Views2,389+9%vs avg
Forwards4
Reactions35
Comments—
#1395Video
Views2,501+14%vs avg
Forwards9
Reactions117
Comments—
#1394Text
Views2,582+18%vs avg
Forwards11
Reactions152
Comments—
#1392Videoedited
Views2,436+11%vs avg
Forwards10
Reactions27
Comments—